Evidence map›Paper›PMID 10417269›Full record

ReviewAmerican journal of human genetics1999

The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

A DeSandro, U M Nagarajan, J M Boss

Abstract readReview
In one paragraph

Review in American journal of human genetics, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Heart Regeneration for Clinical Application.Internal medicine (Tokyo, Japan) · 2026
    Review
  2. Review
  3. Spatially resolved C1QCCell discovery · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. "Off-the-Shelf" Allogeneic CAR Cell Therapy-Neglected HvG Effect.Current treatment options in oncology · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Macrophage-specific MHCII expression is regulated by a remoteThe Journal of experimental medicine · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

A DeSandroDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
U M Nagarajan
J M Boss

Funding

Regulation of MHC Class II GenesR01GM047310 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2015
$4.6M
MHC Class II Transactivator Function and RegulationR01AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2009
$2.6M
Regulation of the MHC Class II Transactivator CIITAR56AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2010 to 2010
$383k
MHC Class II Bare Lymphocyte Syndrome factorsR21AI034000 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2003 to 2003
$342k
MHC CLASS II AND FETAL/MATERNAL IMMUNITYR01HD034440 · NICHD · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1996 to 2000
$273k
NIAID NIH HHS AI34000NICHD NIH HHS HD34440NIGMS NIH HHS GM47310
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression RegulationGenes, MHC Class IIGenetic Complementation TestHumansModels, GeneticSevere Combined Immunodeficiency

Identifiers

PMID10417269
PMCPMC1377925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.